Heart failure (HF) is a growing global health concern, affecting more than 64 million people worldwide. It develops when the heart can no longer pump enough blood to meet the body's demands, often due ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

The data, published in the Journal of the American Heart Association, analyzed over 37 million heart disease deaths spanning ...

There are consistent associations between elevated urinary metal levels and increased HF risk over time across geographically diverse cohorts of adults.

A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.

People may experience different symptoms of heart failure (congestive heart failure) depending on how much of the heart’s pumping capacity has been affected.

BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ ...

In systolic heart failure, the left ventricle becomes weak and can't contract and work the way it should. There's no cure, but you can make lifestyle changes to help treat it.

Some everyday meds may quietly harm your heart. A cardiologist reveals 5 common drugs that could pose hidden risks to your cardiovascular health.

Bayer presents Kerendia data in heart failure with preserved and mildly reduced LVEF at ESC, sparking debate about how it may fit into treatment.

Eli Lilly's tirzepatide has significantly cut cardiovascular risks in patients with obesity and heart failure with preserved ejection fraction.

In this Review, Narula et al. discuss the role of apoptosis in systolic dysfunction and heart failure, and in the development of novel strategies for the management of heart failure.